ARTICLE | Company News
Sequitur, Bristol-Myers deal
March 10, 2003 8:00 AM UTC
The companies extended a 2001 deal under which Sequitur is performing biological screening and supplying its RNAi antisense compounds to BMY for use in the pharma company's functional genomics-based t...